1. ホーム
  2. 一覧
論文 特許

論文 - 一覧

  • 21 Hits
  • 検索条件 : 絞込み (MeSH = Sorafenib)
生物種 リソース名 タイトル
ヒト・動物細胞 HuH-6(RCB1367) The Collagen Gel Droplet-embedded Culture Drug Sensitivity Test in Relapsed Hepatoblastoma.
ヒト・動物細胞 Hep G2 Activated p53 with Histone Deacetylase Inhibitor Enhances L-Fucose-Mediated Drug Delivery through Induction of Fucosyltransferase 8 Expression in Hepatocellular Carcinoma Cells.
メダカ fli1::GFP (TG1206) , Kyoto-Cab Effect of histidine on sorafenib-induced vascular damage: Analysis using novel medaka fish model.
ヒト・動物細胞 RBE(RCB1292) , YSCCC(RCB1549) Survival pathway of cholangiocarcinoma via AKT/mTOR signaling to escape RAF/MEK/ERK pathway inhibition by sorafenib.
ヒト・動物細胞 Hep G2(RCB1886) , PK-1(RCB1972) , KLM-1(RCB2138) Questiomycin A stimulates sorafenib-induced cell death via suppression of glucose-regulated protein 78.
ヒト・動物細胞 HuCCT1(RCB1960) Gemcitabine and Oxaliplatin, but Not Sorafenib or Paclitaxel, Have a Synergistic Effect with Yttrium-90 in Reducing Hepatocellular Carcinoma and Cholangiocarcinoma Cell Line Viability.
ヒト・動物細胞 LC-2/ad(RCB0440) EGF Induced RET Inhibitor Resistance in CCDC6-RET Lung Cancer Cells.
ヒト・動物細胞 HS-Sch-2(RCB2230) , HS-PSS(RCB2362) Sec6/8 regulates Bcl-2 and Mcl-1, but not Bcl-xl, in malignant peripheral nerve sheath tumor cells.
ヒト・動物細胞 HuH-7 Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.
ヒト・動物細胞 Hep G2 , HuH-7 Combining celecoxib with sorafenib synergistically inhibits hepatocellular carcinoma cells in vitro.
ヒト・動物細胞 Hep G2 , HuH-7 Sorafenib and TRAIL have synergistic effect on hepatocellular carcinoma.
ヒト・動物細胞 HuH-7 Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib.
ヒト・動物細胞 HuH-7 Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma.
ヒト・動物細胞 Hep G2 , HuH-7 Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma.
ヒト・動物細胞 Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib.
ヒト・動物細胞 HuH-7 Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma.
ヒト・動物細胞 KU812(RCB0495) , K562 Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway.
ヒト・動物細胞 Li-7(RCB1941) Identification of a unique hepatocellular carcinoma line, Li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib.
メダカ HBK11-Tg(Tyr-p-loxp-EGFP-loxp-HRASG12V)3 (TG925) , HBK11-Tg(Tyr-p-loxp-EGFP-loxp-HRASG12V)5 (TG926) , HBK11-Tg(Tyr-p-loxp-EGFP-loxp-HRASG12V)6 (TG927) , HBK11-Tg(Tyr-p-loxp-EGFP-loxp-HRASG12V)15 (TG928) , HB11A (IB185) Establishment of HRAS(G12V) transgenic medaka as a stable tumor model for in vivo screening of anticancer drugs.
ヒト・動物細胞 YSCCC(RCB1549) , HuH-28(RCB1943) Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells.